Navigation Links
Xencor Receives U.S. Patent for Monoclonal Antibody Engineering that Extends Duration of Action
Date:1/6/2012

MONROVIA, Calif., Jan. 6, 2012 /PRNewswire/ -- Xencor, Inc., a company using its proprietary Protein Design Automation® (PDA) platform technology to engineer next-generation antibodies, announced today that the U.S. Patent and Trademark Office has issued Xencor a broad patent covering optimized monoclonal antibody variants and their application for extending in vivo half-life of  antibodies. U.S. Patent 8,088,376 is the latest in Xencor's expanding portfolio of patents covering antibody drug candidates and engineering technology to impart specific therapeutic properties, including antibody-dependent cell cytotoxicity (ADCC), immunomodulation and increased half-life and efficacy.

"The issuance of this new patent covers the key element of Xencor's Xtend™ half-life prolongation technology and supports the work we are doing in collaboration with pharmaceutical industry partners to incorporate this technology in multiple drug candidates and to develop biosuperior versions of approved antibodies," said Bassil Dahiyat, Ph.D., president and CEO of Xencor. "Our PDA technology platform has enabled Xencor to develop an extensive pipeline of clinical-stage products, and our strong patent portfolio positions the company to be a leader in the development of best-in-class antibody therapeutics."

The patent covers amino acid modifications in the Fc domain, part of the constant region of antibodies that improves serum half-life by 2 to 3 fold over native antibodies. Longer half-lives allows for reduced dosing frequency, lower dosing, and potentially improved tolerability and efficacy.

Xencor's intellectual property portfolio now consists of 47 U.S. and 36 foreign issued patents and numerous pending patents for protein and antibody engineering.

About Xtend™ technology

Xencor's proprietary antibody technology platform provides a validated solution to enhancing the serum half-life of immunoglobulin molecules.
'/>"/>

SOURCE Xencor, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
5. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
6. CryoCor Receives FDA Approval for Right Atrial Flutter
7. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
8. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
9. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
10. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
11. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... TAMPA, Fla. , July 31, 2015 /PRNewswire/ ... announced today that it has made a structured ... -based company specializing in milling, micronization and ... investment will help grow Powdersize,s business while simultaneously ... solutions to Xcelience,s portfolio of capabilities. ...
(Date:7/31/2015)... LAKE, N.J. and SAN DIEGO ... today that its parent company Eisai Co., Ltd. (Headquarters: ... Haruo Naito , "Eisai") and Halozyme Therapeutics, Inc. (Headquarters: ... CEO: Dr. Helen Torley , "NASDAQ: HALO") have ... mesylate (brand name: Halaven ® , "eribulin") in combination ...
(Date:7/30/2015)... Edwards Lifesciences Corporation (NYSE: EW ), the global leader ... announced that Robert A. Ingram has retired from ... ardent champion for innovation in the lifesciences industry, and it ... board as we pursue our focused innovation strategy," said ... provided a valuable perspective to our board, drawing on his ...
Breaking Medicine Technology:Xcelience Makes Structured Cash Investment in Powdersize 2Xcelience Makes Structured Cash Investment in Powdersize 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6
... /PRNewswire/ -- A new study suggests,strong variation in ... U.S. Anaphylaxis is a severe allergic,reaction that can ... differences in EpiPen prescribing, a marker of,anaphylaxis risk, ... low levels of vitamin D,from lack of sunshine, ...
... Journal of the,American Society of Clinical Oncology has ... by Dr. Siu-Fun Wong, and her,colleagues, which concluded ... reduction in the pain and,itching of a rash ... as EGFR inhibitors. This ongoing supportive care trial ...
Cached Medicine Technology:Large Geographic Differences in EpiPen Prescriptions in the U.S.,From the Journal of Allergy and Clinical Immunology 2Clinical Study Shows Regenecare Relieves Pain and Itching of Skin,Rashes Caused by Widely Used Cancer Drugs 2
(Date:8/1/2015)... ... August 01, 2015 , ... Have you ever wondered what “Karma” really means? Does ... the word “Karma.” , Vedic tradition, which gave birth to Hinduism, is one of ... the central concepts of this tradition. According to the wisdom of this heritage, Karma is ...
(Date:8/1/2015)... ... 2015 , ... Calvary Hospital today announced that it is embarking on a ... is to bring this Torah – dating from 1880 – back to kosher status, ... , Scroll No. 515, from the town of Taus-Domazlice, is on permanent loan ...
(Date:8/1/2015)... ... ... Brig and Lita Hart, icons of the network marketing industry and founders ... with the HOPE Movement of EvolvHealth. In what has been a long-term relationship between ... join their missions of purpose together to change the course of the network marketing ...
(Date:8/1/2015)... ... August 01, 2015 , ... On Tuesday, July 28th, Symantec ... are thought to have been behind the attack on Anthem Inc. which resulted in ... day exploits, watering hole attacks and spear phishing campaigns. , For Joe ...
(Date:8/1/2015)... ... 01, 2015 , ... BeverlyD, owner and founder of BeverlyD Luxe Organic Hair ... first small business donation to kick off the campaign for healing and Well-Being. , ... includes a complete line of raw, organic hair care products, as well as her ...
Breaking Medicine News(10 mins):Health News:Nithyananda Yoga Foundation to Conduct Global Webinar on Karma at No Charge on August 1st 2Health News:Calvary Hospital Announces Plans to Restore Historic Torah 2Health News:Calvary Hospital Announces Plans to Restore Historic Torah 3Health News:Looking for HOPE? Healthy Home Has Evolv’d 2Health News:Looking for HOPE? Healthy Home Has Evolv’d 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 2Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 4Health News:March4thforWellBeing Foundation Kickoff 2
... Telephone Contact in TreatmentCOLUMBIA, S.C., April 6 ... awarded Silver Honors for Health Plans and Health Networks ... . The honor was announced at the ... and Protection Awards Gala on April 1-2 ...
... achieves record success rates with a breakthrough hypnosis technique to quit ... ... CA (PRWEB) August 15, 2006 -- Franc Tausch, PhD, CCHT, of ... smoking for life by attending one personalized and individual hypnotherapy ...
... Calls on Americans to be Prepared to Offer Contributions, Goods, ... Left HomelessNEW YORK, April 6 The catastrophic earthquake in ... people dead and tens of thousands homeless is a subject ... Citizens Foundation in New York City. "Like all Americans, ...
... could delay orgasm six times longer than before , , ... men with premature ejaculation to delay their orgasm six times ... European men. , The men, with clinically diagnosed premature ejaculation, ... active ingredients (100 men) or the PSD502 spray, which contains ...
... D. Anderson Cancer Center have discovered a gene that protects ... in about half of all breast cancers. , The gene ... in several other types of cancer, the team reports in ... for diminished PTEN protein levels in breast cancer absent a ...
... first four in nation to receive accreditationGREEN BAY, ... Medical Center is one of the first four ... the National Accreditation Program for Breast Centers (NAPBC), ... the first breast program in Wisconsin to earn ...
Cached Medicine News:Health News:Companion Benefit Alternatives Awarded Silver Honors for Best Practices in Health Plans and Health Networks by URAC 2Health News:Companion Benefit Alternatives Awarded Silver Honors for Best Practices in Health Plans and Health Networks by URAC 3Health News:Hypnotherapy Breakthrough: Renowned Smoking Cessation Specialist Helps To Stop Smoking In One Session 2Health News:Topical Spray Helped Men With Premature Ejaculation 2Health News:Gene helps protect tumor suppressor in breast cancer 2Health News:Aurora BayCare is Wisconsin's First Nationally Accredited Breast Program 2
Full Handle Laseredge Slit Blade Knife, 3.0 mm straight. Blade tip dimension: 14.4 mm x 3.0 mm x 3.7 mm....
Full Handle Laseredge Slit Blade Knife, 2.65 mm angled bevel up. Blade tip dimension: 14.4 mm x 2.65 mm x 3.7 mm....
Full Handle Laseredge Implant Blade Knife, 3.2 mm round tip. Blade dimension: 14.4 mm x 3.2 mm x 3.8 mm x 1.65 mm....
Full Handle Laseredge Implant Blade Knife, 4.0 mm straight. Blade dimension: 15.2 mm x 4.0 mm x 3.0 mm x 1.6 mm....
Medicine Products: